# Translational Genomics and Precision Medicine in Cancer Training Program

> **NIH NIH T32** · UNIVERSITY OF TX MD ANDERSON CAN CTR · 2022 · $255,740

## Abstract

PROJECT SUMMARY
There is a critical need to train the next generation of translational cancer researchers in light of a new era of
genomic medicine and big data. We must ensure that scientists are trained in the areas of highest need for
translation of data and experiments into clinical practice. This proposal builds on an existing interdisciplinary
education and research training program developed at MD Anderson Cancer Center, where we have a single
mission to eliminate cancer, in order to expand and enhance the training of outstanding predoctoral and
postdoctoral fellows using an innovative curriculum and multidisciplinary approach centered on core
competencies in state-of-the-art areas of translational research.
Objectives: 1) to provide a comprehensive program with both depth and breadth in areas important to the future
of translational cancer research including translational genomics and precision medicine approaches, early
detection and prognosis of cancer, as well as diagnostic applications; 2) to recruit top predoctoral and
postdoctoral fellows interested in a career in translational cancer research in this area; 3) to provide fellows with
an innovative environment, infrastructure, faculty and administrative support to allow them to make significant
contributions to the field and further the mission of the MD Anderson Cancer Center.
Rationale: Translational Genomics and Precision Medicine in Cancer (TGP) Training Program: The TGP
program will provide the necessary education and training as well as infrastructure and oversight to develop
innovative, big data genome scientists. A highly competitive selection process will identify outstanding
candidates and ensure diversity in the process. Qualified candidates, in addition to a mentored research
experience by one of our outstanding training grant faculty, will gain individualized, interdisciplinary training in
core competency areas critical to the future of translational science in a postgenome world.
Design of T32 Program: The T32 will offer 3 postdoctoral and 1 predoctoral fellowships designed around core
competencies which include: 1) translational cancer research, to gain exposure to mechanistic studies in
translational research and their importance to the human organism; 2) precision medicine to gain experience in
state-of-the-art approaches to diagnose and treat cancer patients; 3) translational genetics and genomics to gain
competency in understanding and implementation of cancer precision medicine; 4) bioinformatics, to learn how
to read and interpret large datasets; and 5) exposure to clinical grand rounds, tumor boards, and industrial
collaborations. Key activities include: grant writing workshops, NIH grant development, and focused mentoring.
All trainees will be required to have strong interest in cancer research and for postdoctorates, experience in
cancer research. Training duration will be 2 years for postdoctoral and up to 3 years for predoctoral fellows with
training faculty...

## Key facts

- **NIH application ID:** 10380570
- **Project number:** 5T32CA217789-05
- **Recipient organization:** UNIVERSITY OF TX MD ANDERSON CAN CTR
- **Principal Investigator:** ANN M KILLARY
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $255,740
- **Award type:** 5
- **Project period:** 2018-04-01 → 2024-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10380570

## Citation

> US National Institutes of Health, RePORTER application 10380570, Translational Genomics and Precision Medicine in Cancer Training Program (5T32CA217789-05). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10380570. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*